New Zealand's COVID‐19 elimination strategy
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Compared with the mitigation and suppression approaches of most Western countries, elimination can minimise direct health effects and offer an early return to social and economic activity O n 23 March 2020, New Zealand committed to an elimination strategy in response to the coronavirus disease 2019 (COVID-19) pandemic. Prime Minister Jacinda Ardern announced that on 26 March, NZ would commence an intense lockdown of the country (the highest level of a four-level response framework 1 ). At the time, NZ had just over 100 COVID-19 cases and no deaths, so this "go early, go hard" approach surprised many. However, there were compelling reasons for NZ to pursue elimination. this article we describe why an elimination strategy made sense for NZ, the distinguishing features of this approach, some of the challenges and how they can be overcome, and where we go from here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
Ferretti, L., Wymant, C., Kendall, M., Zhao, L., Nurtay, A., Abeler-Dörner, L., Parker, M., Bonsall, D., & Fraser, C. (2020) · Science · doi:10.1126/science.abb6936 · Cited by 2,512
Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing
Wang, C. J., Ng, C. Y., & Brook, R. H. (2020) · JAMA · doi:10.1001/jama.2020.3151 · Cited by 1,391
Cowling, B. J., Ali, S. T., Ng, T. W. Y., Tsang, T. K., Li, J. C. M., Fong, M. W., Liao, Q., Kwan, M. Y., Lee, S. L., Chiu, S. S., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30090-6 · Cited by 1,258
Cited by
Impacts of the COVID-19 pandemic on life of higher education students: A global perspective
Aristovnik, A., Keržič, D., Ravšelj, D., Tomaževič, N., & Umek, L. (2020) · Sustainability · doi:10.3390/su12208438 · Cited by 2,047
Islam, N., Shkolnikov, V. M., Acosta, R. J., Klimkin, I., Kawachi, I., Irizarry, R. A., Alicandro, G., Khunti, K., Yates, T., Jdanov, D. A., et al. (2021) · BMJ · doi:10.1136/bmj.n1137 · Cited by 468
Every-Palmer, S., Jenkins, M., Gendall, P., Hoek, J., Beaglehole, B., Bell, C., Williman, J., Rapsey, C., & Stanley, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241658 · Cited by 378
Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
Saad-Roy, C. M., Wagner, C. E., Baker, R. E., Morris, S. E., Farrar, J., Graham, A. L., Levin, S. A., Mina, M. J., Metcalf, C. J. E., & Grenfell, B. T. (2020) · Science · doi:10.1126/science.abd7343 · Cited by 285
Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic
Summers, J., Cheng, H.-Y., Lin, H.-H., Barnard, L. T., Kvalsvig, A., Wilson, N., & Baker, M. G. (2020) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2020.100044 · Cited by 263
Self-citation
Metadata
- Authors
- Baker, M. G., Kvalsvig, A., & Verrall, A. J.
- Venue
- Medical Journal of Australia
- Publisher
- Wiley
- Published
- 2020-08-13
- Volume
- 213
- Issue
- 5
- Pages
- 198
- ISSN
- 0025-729X (ISSN-L)
- 1326-5377
- OpenAlex
- W3027181678
- Cited by
- 131
- References
- 5
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.